Resiniferatoxin , an ultra-potent TRPV1 agonist, induces a depolarization block preventing action potential generation and the transmission of pain. We have developed a polymer-coated RTX nanoparticle cream formulation,(Patent # US-11707437-B2), which has shown efficacy in painful neuropathies.